Strong Evidence Shows IVIg Effectively Treats Certain Neuromuscular Disorders

March 26, 2012 · 2 Comment s

A new AAN guideline provides recommendations for the use of IV immunoglobulin (IVIg) in the treatment of various neuromuscular disorders. “Evidence-based Guideline: IV Immunoglobulin in the Treatment of Neuromuscular Disorders” is published in the March 27, 2012, issue of Neurology®.

 

Strong evidence shows IVIg effectively treats certain neuromuscular disorders. IVIg works as well as plasma exchange to treat Guillain-Barré syndrome (GBS) in adults, and is effective in the long-term treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).

 

IVIg also is effective in treating other neuromuscular diseases, including other forms of neuropathy.

There is moderate evidence for use of this therapy in treating moderate to severe forms of myasthenia gravis and multifocal motor neuropathy.

 

IVIg may help treat nonresponsive dermatomyositis and Lambert-Eaton myasthenic syndrome. There is insufficient evidence to show whether IVIg is effective in the treatment of other neuromuscular disorders such as IgM paraprotein-associated neuropathy, inclusion body myositis, polymyositis, diabetic radiculoplexoneuropathy, or Miller Fisher syndrome, or in the routine treatment of postpolio syndrome.

 

There is insufficient evidence to show whether IVIg is superior or inferior to plasma exchange for treatment of CIDP.

 

High-quality studies are not available on IVIg use in children with GBS. However, because IVIg is effective in adults with GBS, it is reasonable to assume it is also effective in children with GBS. Many people seem to tolerate IVIg therapy; however, hypercoagulability and renal failure, although rare, are of concern.

 

Read the guideline and access PDF summaries for clinicians and patients, a slide presentation, and a clinical example. For more information, contact Julie Cox at jcox@aan.com or (651) 332-8684.

Tags: American Academy of Neurology · evidence-based medicine · guideline · neurology

2 response s so far ↓

  • 1 Holly Adams // Apr 25, 2012 at 12:22 PM

    Hello: I am curious to know if this treatment would benefit myself ?(IVIg). I have periphreal neuropathy caused from chemo. I thought I read about a neurologist in the Atlanta,Ga. area that is having great results with this treatment. Would you be able to let me know about this doctor? He was mentioned in one of the earlier editions of neurology magazine.
    Sincerely, Holly adams
  • 2 Julie Cox // Apr 25, 2012 at 1:47 PM

    Hi, Holly--

    Thank you for your post. Although the AAN cannot provide guidance in determining whether a particular intervention would be beneficial for you, I can direct you to our patient website (http://patients.aan.com/), where you will find links to many resources, including a search tool to locate a neurologist near you. Perhaps you will be able to locate the neurologist in question through that search feature. You can access the Find a Neurologist Tool at this link: http://patients.aan.com/findaneurologist/

    All the best in your search!

    Julie Cox

Leave a Comment

Comment

Leave this field empty:



AAN Guidelines Exchange: Evidence and More

We hope the conversations that take place on this blog will be energetic, constructive, professional, and stimulating. We ask that you adhere to the following guidelines.
  1. Please identify yourself when you post. Anonymous entries will not be approved by the administrator.
  2. We want to keep this an ad-free zone. Please refrain from soliciting business for your products and services.
  3. Feel free to offer critical commentary about the ideas and processes discussed here and refrain from being critical of the people who post about them.

Blog Feed & Archives

Recent Entries

Categories

Monthly Archives